摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 5-chloro-2-hydroxy-3-nitrobenzoate | 159323-96-3

中文名称
——
中文别名
——
英文名称
ethyl 5-chloro-2-hydroxy-3-nitrobenzoate
英文别名
——
ethyl 5-chloro-2-hydroxy-3-nitrobenzoate化学式
CAS
159323-96-3
化学式
C9H8ClNO5
mdl
——
分子量
245.619
InChiKey
UPPGKFOEZDUZBC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    92.4
  • 氢给体数:
    1
  • 氢受体数:
    5

安全信息

  • 储存条件:
    存储条件:2-8°C,干燥。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    ethyl 5-chloro-2-hydroxy-3-nitrobenzoate 在 palladium on activated charcoal 、 Rh/Al2O3 氢气对甲苯磺酸溶剂黄146三乙胺 作用下, 以 1,4-二氧六环乙醇 为溶剂, 25.0~100.0 ℃ 、101.33 kPa 条件下, 反应 83.0h, 生成 Ethyl 4,4-dimethylpyrrolo[2,1-c][1,4]benzoxazine-6-carboxylate
    参考文献:
    名称:
    新的5-HT3(5-羟色胺3)受体拮抗剂。V.吡咯并[2,1-c] [1,4]苯并恶嗪-6-羧酰胺的合成和构效关系。
    摘要:
    本文介绍了结构新颖的杂环羧酰胺的发现,该酰胺是高效的5-HT3(5-羟色胺3)受体拮抗剂。发现吡咯并[2,1-c] [1,4]苯并恶嗪-6-羧酰胺(12和20)对麻醉大鼠的von Bezold-Jarisch反射具有有效的5-HT3受体拮抗剂活性。结构活性研究表明,在芳族环部分的8位上具有小的亲脂性取代基(如氯和甲基)的化合物保留了较高的效价,而具有庞大的取代基的化合物则基本无活性。在4-位的二甲基基团稍微降低了效力。1-氮杂双环[2.2.2]辛-3-胺作为胺部分提供了最有效的活性。在这个系列中,发现20a是最有效的5-HT3受体拮抗剂,
    DOI:
    10.1248/cpb.43.1358
  • 作为产物:
    描述:
    5-氯代水杨酸硫酸硝酸 作用下, 以 为溶剂, 反应 5.67h, 生成 ethyl 5-chloro-2-hydroxy-3-nitrobenzoate
    参考文献:
    名称:
    Development of a Phase-Transfer-Catalyzed, [2,3]-Wittig Rearrangement
    摘要:
    An investigation into the use of phase-transfer catalysis for the [2,3]-sigmatropic rearrangement of allyloxy carbonyl compounds is described. Initial studies focused on identifying viable substrate classes that would undergo selective [2,3]-rearrangement under phase-transfer catalysis. Under certain conditions, the [2,3]-sigmatropic rearrangement of allyloxy carbonyl compounds takes place in the presence of a phase-transfer agent, providing a rare example of a phase-transfer-catalyzed unimolecular reaction. In the course of this investigation, it was found that catalysis is dependent on several variables including base concentration, catalyst structure, and substrate lipophilicity. Preliminary testing of chiral, nonracemic phase-transfer catalysts has shown promising levels of enantioselectivity for future development.
    DOI:
    10.1021/acs.joc.5b01759
点击查看最新优质反应信息

文献信息

  • BENZOXAZOLE DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
    申请人:Shudo, Koichi
    公开号:EP1134220B1
    公开(公告)日:2004-08-18
  • Synthesis and Enzymic Evaluation of Conformationally Defined Carnitine Analogs
    作者:Wayne J. Brouillette、Ashraf Saeed、Ahmed Abuelyaman、Tracy L. Hutchison、Paul E. Wolkowicz、Jeanie B. McMillin
    DOI:10.1021/jo00094a049
    日期:1994.7
    Carnitine (1, 3-hydroxy-4-trimethylammoniobutyrate) is essential as a donor and acceptor of acyl groups in cellular metabolism. The major solution conformation of carnitine about C3-C4 contains the gauche relationship between the trimethylammonium and hydroxy groups, while two of the three low-energy, staggered conformations about C2-C3 are significantly populated. For studies of carnitine's protein binding sites, we designed conformationally defined cyclohexyl carnitine analogs (2-hydroxy-3-trimethylammoniocyclohexanecarboxylate) which all contain the favored carnitine conformation about the C3-C4 bond. Of the four possible diastereomers for these analogs, we synthesized three (2-4) that contain different carnitine conformations about C2-C3. Diastereomers 2 and 3 were prepared via the major diastereomeric products resulting from reduction of ethyl 5-chloro-3-nitrosalicylate (7). Compound 4, which could not be obtained in practical quantities by the above method, was prepared stereoselectively via opening of the epoxide of 3-(benzyloxycarbonylamino)cyclohexene (23) with Et(2)AlCN. Compounds 2-4 were not substrates for pigeon breast carnitine acetyltransferase but were weak, competitive inhibitors with K-i values from 2.9 to 4.1 mM. In contrast, compounds 2 and 4 were not inhibitors of neonatal rat cardiac myocyte CPT-2, while compound 3 was a modest competitive inhibitor (K-i 5.3 mM). These results suggest differences between the carnitine binding sites of CAT and CPT-2.
  • Smith; Peirce, American Chemical Journal, 1879, vol. 1, p. 176
    作者:Smith、Peirce
    DOI:——
    日期:——
  • A microchip-laser-pumped DFB-polymer-dye laser
    作者:T. Voss、D. Scheel、W. Schade
    DOI:10.1007/s003400100619
    日期:2001.8
    A miniaturized, high repetition rate, picosecond all solid state photo-induced distributed feedback (DFB) polymer-dye laser is described by applying a passively Q-switched and frequency-doubled Cr4+:Nd3+:YAG-microchip laser (pulse width Delta tau = 540ps, repetition rate nu = 3 kHz, pump energy E-pump = 0.15 muJ) as a pump source. A poly-methylmethacrylate film doped with rhodamine B dye serves as active medium. The DFB-laser pulses are temporally and spectrally characterized, and the stability of the thin polymer/dye film at high repetition rates is analyzed. The shortest DFB-laser pulses obtained have a duration of 11 ps. After the emission of 350 000 pulses the intensity of the DFB-laser output has decreased by a factor of two and the pulse duration has increased by a factor of 1.2. For single DFB-laser pulses of 20-ps duration the spectral bandwidth is measured to be Delta lambda = 0.03 nm, which is only 0.005 nm above the calculated Fourier limit assuming a Gaussian profile for the temporal shape of the pulses. Coarse wavelength tuning of the DFB laser between 590 and 619 nm is done by turning the prism. Additionally, a fine tuning of the DFB-polymer-laser wavelength is achieved by changing the temperature of the polymer/dye layer ( d lambda /dT = -0.05 nm/degreesC) in the range from 20 to 40 degreesC.
  • US7045516B1
    申请人:——
    公开号:US7045516B1
    公开(公告)日:2006-05-16
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐